Jaguar Gene Therapy, LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases including those that impact sizeable patient populations. The company is made up of a proven team of experts with unparalleled CMC (Chemistry, Manufacturing and Controls), regulatory, clinical and commercial acumen who have first-hand experience in bringing novel gene therapy treatments to patients and their families. Committed to patient safety and product purity, Jaguar is rapidly advancing an initial pipeline of three programs targeting: 1) Type 1 galactosemia; 2) a genetic cause of autism spectrum disorder and Phelan-McDermid syndrome and other severe neurodevelopmental disorders with a SHANK3 mutation or deletion; and 3) Type 1 diabetes. The company continues to evaluate opportunities to expand its pipeline using the strength of the team and close relationships with numerous academic institutions.
Location: United States, Illinois, Lake Forest
Employees: 51-200
Founded date: 2019
Investors 2
| Date | Name | Website |
| 22.09.2024 | T1D Fund | t1dfund.or... |
| 26.03.2022 | ARCH Ventu... | archventur... |
Mentions in press and media 1
| Date | Title | Description |
| - | Jaguar Gene Therapy Launches with Mission to Accelerate Breakthroughs in Gene Therapy for Patients Suffering from Severe Genetic Diseases | LAKE FOREST, Ill.--(BUSINESS WIRE)--Feb 25, 2021-- Jaguar Gene Therapy launched today after being in stealth mode for the past year and is uniquely positioned to accelerate gene therapy development. Led by the former AveXis leadership and r... |